通过T7RNA聚合酶及其C螺旋突变体进行DNA终端依赖转录
Bingbing Yu1, Yifan Chen1, Yan Yan1
1Key Laboratory of Molecular Biophysics, Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei 430074, China.
Nucleic acids research
|July 9, 2024
概括
使者RNA (mRNA) 疫苗看起来很有希望,但T7RNA聚合酶产生双链RNA (dsRNA) 免疫触发器. 一个T7聚合酶突变显著减少dRNA,改善mRNA表达和降低免疫原性,以获得更好的疫苗和治疗应用.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 疫苗开发 疫苗开发
背景情况:
- 使者RNA (mRNA) 技术是疫苗和治疗的强大平台.
- 使用T7RNA聚合酶进行体外转录通常会产生双链RNA (dsRNA) 副产品.
- 这种dsRNA可以激活哺乳动物的先天免疫系统,从而可能降低mRNA的有效性.
研究的目的:
- 为了确定在体外转录过程中产生的全长dsRNA的主要来源.
- 研究减少T7RNA聚合酶dSRNA生成的方法.
- 评估减少dsRNA对mRNA表达效率和免疫性的影响.
主要方法:
- 研究了DNA末端启动的转录作为dsRNA的来源.
- 分析了DNA模板终端核酸 (瓜诺或细胞) 对转录的影响.
- 通过改变C-螺旋体中的芳香残留物来设计了一个T7RNA聚合酶突变体 (G47W).
- 比较野生型和突变T7RNA聚合酶产生的mRNA表达和免疫性.
主要成果:
- 确定了DNA末端启动的转录作为全长dsrna的主要来源.
- 发现DNA模板上的终端关氨酸或细胞氨酸增强了这种转录.
- 证明T7RNA聚合酶中的G47W突变显著降低了dsRNA的产生.
- 使用G47W突变体合成的mRNA显示出更高的表达效率和更低的免疫性.
结论:
- T7RNA聚合酶的DNA末端启动的转录是dsRNA副产品的主要原因.
- 像G47W这样的T7RNA聚合酶中的特定突变可以减轻dsRNA的形成.
- 通过减少dsRNA优化mRNA生产为基于mRNA的疫苗和疗法提供了更好的潜力.
相关概念视频
Bacterial Transcription
28.1K
RNA polymerase (RNAP) carries out DNA-dependent RNA synthesis in both bacteria and eukaryotes. Bacteria do not have a membrane-bound nucleus. So, transcription and translation occur simultaneously, on the same DNA template.
Transcription can be divided into three main stages, each involving distinct DNA sequences to guide the polymerase. These are:
Transcription can be divided into three main stages, each involving distinct DNA sequences to guide the polymerase. These are:
28.1K
Transcription Attenuation in Prokaryotes
15.2K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
15.2K
Transcription Initiation
16.4K
Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
The promoters and enhancers and their accessory proteins allow tight regulation of...
16.4K
Eukaryotic RNA Polymerases
24.1K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
24.1K
RNA Polymerase II Accessory Proteins
9.2K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.2K
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K


